Cargando…

A Call to Action: Integration of Buprenorphine Prescribing Into the Care of Persons With Human Immunodeficiency Virus and Opioid Use Disorder

During the coronavirus disease 2019 (COVID-19) pandemic, we also experienced a worsening opioid overdose epidemic. Untreated opioid use disorder (OUD) in persons with human immunodeficiency virus (HIV) is associated with worse HIV-related outcomes. Buprenorphine is a safe, evidence-based medication...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fujita, A Wendy, Wilson, J Deanna, Kennedy, Amy J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Perspectives
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9384664/ https://www.ncbi.nlm.nih.gov/pubmed/36039099 http://dx.doi.org/10.1093/ofid/ofac400

Ejemplares similares

Long-Acting Buprenorphine Formulations as a New Strategy for the Treatment of Opioid Use Disorder
por: Maremmani, Icro, et al.
Publicado: (2023)

Prescribing of Opioid Analgesics and Buprenorphine for Opioid Use Disorder During the COVID-19 Pandemic
por: Currie, Janet M., et al.
Publicado: (2021)

Personalized Care in Opioid Use Disorder maintained on Buprenorphine
por: Elarabi, H., et al.
Publicado: (2022)

Evaluating buprenorphine prescribing and opioid-related health outcomes following the expansion the buprenorphine waiver program
por: Rowe, Christopher L., et al.
Publicado: (2022)

Prescribing Characteristics Associated With Opioid Overdose Following Buprenorphine Taper
por: Bozinoff, Nikki, et al.
Publicado: (2022)

Managing opioid withdrawal precipitated by buprenorphine with buprenorphine
por: Oakley, Bridget, et al.
Publicado: (2021)

Trends in Buprenorphine Prescribing for Opioid Use Disorder by Psychiatrists in the US From 2003 to 2021
por: Creedon, Timothy B., et al.
Publicado: (2023)

Characteristics and Prescribing Patterns of Clinicians Waivered to Prescribe Buprenorphine for Opioid Use Disorder Before and After Release of New Practice Guidelines
por: Jones, Christopher M., et al.
Publicado: (2023)

Characteristics of opioid prescribing to outpatients with chronic liver diseases: A call for action
por: Agbalajobi, Olufunso M., et al.
Publicado: (2021)

Economic Evaluation of Extended-Release Buprenorphine for Persons With Opioid Use Disorder
por: Flam-Ross, Juliet M., et al.
Publicado: (2023)

A call for better validation of opioid overdose risk algorithms
por: McElfresh, Duncan C, et al.
Publicado: (2023)

An answered call for aid? Cannabinoid clinical framework for the opioid epidemic
por: Hammaker, Krista, et al.
Publicado: (2023)

Staying Engaged in Your Career Without Burning Out: A Call for Action to Build Resilience
por: Kennedy, Beth B., et al.
Publicado: (2020)

Buprenorphine‐naloxone, buprenorphine, and methadone throughout pregnancy in maternal opioid use disorder
por: Kanervo, Minna M., et al.
Publicado: (2022)

Molecular biology for green recovery—A call for action
por: Rodríguez-Martínez, Marta, et al.
Publicado: (2022)

Prescribing Buprenorphine for Opioid Use Disorders in the ED: A Review of Best Practices, Barriers, and Future Directions
por: Cao, Scott S, et al.
Publicado: (2020)

Methadone and buprenorphine-related deaths among people prescribed and not prescribed Opioid Agonist Therapy during the COVID-19 pandemic in England
por: Aldabergenov, D, et al.
Publicado: (2022)

Association of Project ECHO Training With Buprenorphine Prescribing by Primary Care Clinicians in Minnesota for Treating Opioid Use Disorder
por: Solmeyer, Anna R., et al.
Publicado: (2022)

Call to action: improving primary care for women with COPD
por: Tsiligianni, Ioanna, et al.
Publicado: (2017)

Calling for a united action to defeat COVID-19
por: Overby, Madison, et al.
Publicado: (2020)

Call to Action for Enhanced Equity and Inclusion in Cannabis Research
por: Martin-Willett, Renée, et al.
Publicado: (2021)

A Call to Action for Gender Equity in Climate Leadership
por: Wray, Britt, et al.
Publicado: (2023)

Call to Action for Advancing Equitable Genomic Newborn Screening
por: Ersig, Anne L., et al.
Publicado: (2023)

The cholera outbreak in Syria: a call for urgent actions
por: Alhaffar, MHD Bahaa Aldin, et al.
Publicado: (2023)

Immune Literacy: a Call to Action for a System-Level Change
por: Mixter, Philip F., et al.
Publicado: (2023)

A collaborative opioid prescribing (CoOP) model linking opioid treatment programs with office-based buprenorphine providers
por: Stoller, Kenneth B
Publicado: (2015)

Open peer review urgently requires evidence: A call to action
por: Ross-Hellauer, Tony, et al.
Publicado: (2023)

Peripartum and Postpartum Analgesia and Pain in Women Prescribed Buprenorphine for Opioid Use Disorder Who Deliver by Cesarean Section
por: O’Connor, Alane B, et al.
Publicado: (2022)

Comparison of Buprenorphine and Buprenorphine/naloxone in Detoxification of Opioid-dependent Men
por: Ziaaddini, Hassan, et al.
Publicado: (2018)

The opioid‐impaired provider: A call for national guidance to maximize rehabilitation while protecting patient safety
por: Watson, Gretchen LeFever, et al.
Publicado: (2020)

A Call for Better Opioid Prescribing Training and Education
por: Khidir, Hazar, et al.
Publicado: (2016)

The Pharmacology of Buprenorphine Microinduction for Opioid Use Disorder
por: De Aquino, Joao P., et al.
Publicado: (2021)

Characteristics and correlates of U.S. clinicians prescribing buprenorphine for opioid use disorder treatment using expanded authorities during the COVID-19 pandemic
por: Jones, Christopher M., et al.
Publicado: (2021)

Tracking Career Outcomes for Postdoctoral Scholars: A Call to Action
por: Silva, Elizabeth A., et al.
Publicado: (2016)

Low availability of code in ecology: A call for urgent action
por: Culina, Antica, et al.
Publicado: (2020)

Medicalization of poverty: a call to action for America’s healthcare workforce
por: Jones, Danielle D
Publicado: (2022)

Obesity in the USMLE Step 1 examination: A call to action
por: Olson, Amber, et al.
Publicado: (2023)

A qualitative examination of the current management of opioid use disorder and barriers to prescribing buprenorphine in a Canadian emergency department
por: Wiercigroch, David, et al.
Publicado: (2021)

Self-reported Use of Prescribed Buprenorphine Among US Adults With Nonmedical Use of Prescription Opioids Motivated by Pain
por: Buonora, Michele J., et al.
Publicado: (2022)

Development of point-of-care testing devices to improve clozapine prescribing habits and patient outcomes
por: Kalaria, Shamir N, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_o0a67uv6r2ahbvjd8e801lagjs